郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Noribogaine is a G-protein biased κ-opioid receptor agonist.

期刊：Neuropharmacology发表年份：2015作者：Emeline L Maillet; Nicolas Milon; Mari D Heghinian; James Fishback; Stephan C Schürer; Nandor Garamszegi; Deborah C Mash
阅读更多 →

药效评价Absolute Quantitation of Intact Recombinant Antibody Product Variants Using Mass Spectrometry.

期刊：Analytical chemistry发表年份：2015作者：Frank D Macchi; Feng Yang; Charlene Li; Chenchen Wang; Anh Nguyen Dang; Joseph C Marhoul; Hui-min Zhang; Timothy Tully; Hongbin Liu; X Christopher Yu; David A Michels
阅读更多 →

药效评价Benzazaborinines as Novel Bioisosteric Replacements of Naphthalene: Propranolol as an Example.

期刊：Journal of medicinal chemistry发表年份：2015作者：Frederik J R Rombouts; Fulgencio Tovar; Nigel Austin; Gary Tresadern; Andrés A Trabanco
阅读更多 →

药效评价Further studies on pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonists.

期刊：European journal of medicinal chemistry发表年份：2015作者：Maria Paola Giovannoni; Giovanna Ciciani; Agostino Cilibrizzi; Letizia Crocetti; Simona Daniele; Lorenzo Di Cesare Mannelli; Carla Ghelardini; Chiara Giacomelli; Gabriella Guerrini; Claudia Martini; Maria Letizia Trincavelli; Claudia Vergelli
阅读更多 →